Skip to content | Skip to institutional links

Common menu bar links

This Web page has been archived on the Web.

Left hand menu

Canada Gazette
Consultation
- What is the consultation process?
- Current Consultations
Archives
Publishing Information
Resources
Stay in Touch
- RSS Feeds
Proactive Disclosure
- Proactive Disclosure

Vol. 139, No. 46 — November 12, 2005

COMMISSIONS

CANADA CUSTOMS AND REVENUE AGENCY

INCOME TAX ACT

Revocation of registration of a charity

The following notice of proposed revocation was sent to the charity listed below revoking it for failure to meet the parts of the Income Tax Act as listed in this notice:

"Notice is hereby given, pursuant to paragraphs 168(1)(b), 168(1)(d) and 168(1)(e) of the Income Tax Act, that I propose to revoke the registration of the charity listed below and that by virtue of paragraph 168(2)(b) thereof, the revocation of the registration is effective on the date of publication of this notice in the Canada Gazette."

Business Number	Name/Address
873427462RR0001	SP CLUB SOCIETY, SURREY, B.C.

ELIZABETH TROMP
Director General
Charities Directorate

[46-1-o]

CANADIAN INTERNATIONAL TRADE TRIBUNAL

ORDERS

Refined sugar

In the matter of an expiry review, under subsection 76.03(3) of the Special Import Measures Act, of the orders made by the Canadian International Trade Tribunal on November 3, 2000, in Review No. RR-99-006, continuing, with amendment, its findings made on November 6, 1995, in Inquiry No. NQ-95-002, concerning the dumping of refined sugar originating in or exported from the United States of America, Denmark, the Federal Republic of Germany, the Netherlands and the United Kingdom, and the subsidizing of refined sugar originating in or exported from the European Union

The Canadian International Trade Tribunal, under the provisions of subsection 76.03(3) of the Special Import Measures Act, has conducted an expiry review (Expiry Review No. RR-2004-007) of its orders made on November 3, 2000, in Review No. RR-99-006, continuing, with amendment, its findings made on November 6, 1995, in Inquiry No. NQ-95-002, concerning the dumping of refined sugar originating in or exported from the United States of America, Denmark, the Federal Republic of Germany, the Netherlands and the United Kingdom, and the subsidizing of refined sugar originating in or exported from the European Union.

Pursuant to paragraph 76.03(12)(b) of the Special Import Measures Act, the Canadian International Trade Tribunal hereby continues its order in respect of the dumping of refined sugar originating in or exported from Denmark, the Federal Republic of Germany, the Netherlands and the United Kingdom, and the subsidizing of refined sugar originating in or exported from the European Union, with an amendment to exclude individually wrapped rectangular cane sugar tablets.

Pursuant to subsection 76.04(1) of the Special Import Measures Act, the Canadian International Trade Tribunal also hereby continues its order in respect of the dumping of refined sugar originating in or exported from the United States of America, with an amendment to exclude individually wrapped rectangular cane sugar tablets.

Ottawa, November 2, 2005

HÉLÈNE NADEAU
Secretary

[46-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

NOTICE TO INTERESTED PARTIES

The following notices are abridged versions of the Commission's original notices bearing the same number. The original notices contain a more detailed outline of the applications, including additional locations and addresses where the complete files may be examined. The relevant material, including the notices and applications, is available for viewing during normal business hours at the following offices of the Commission:

— Central Building, Les Terrasses de la Chaudière, Room 206, 1 Promenade du Portage, Gatineau, Quebec K1A 0N2, (819) 997-2429 (telephone), 994-0423 (TDD), (819) 994-0218 (fax);

— Metropolitan Place, Suite 1410, 99 Wyse Road, Dartmouth, Nova Scotia B3A 4S5, (902) 426-7997 (telephone), 426-6997 (TDD), (902) 426-2721 (fax);

— Kensington Building, Suite 1810, 275 Portage Avenue, Winnipeg, Manitoba R3B 2B3, (204) 983-6306 (telephone), 983-8274 (TDD), (204) 983-6317 (fax);

— 530-580 Hornby Street, Vancouver, British Columbia V6C 3B6, (604) 666-2111 (telephone), 666-0778 (TDD), (604) 666-8322 (fax);

— CRTC Documentation Centre, 205 Viger Avenue W, Suite 504, Montréal, Quebec H2Z 1G2, (514) 283-6607 (telephone), 283-8316 (TDD), (514) 283-3689 (fax);

— CRTC Documentation Centre, 55 St. Clair Avenue E, Suite 624, Toronto, Ontario M4T 1M2, (416) 952-9096 (telephone), (416) 954-6343 (fax);

— CRTC Documentation Centre, Cornwall Professional Building, Room 103, 2125 11th Avenue, Regina, Saskatchewan S4P 3X3, (306) 780-3422 (telephone), (306) 780-3319 (fax);

— CRTC Documentation Centre, 10405 Jasper Avenue, Suite 520, Edmonton, Alberta T5J 3N4, (780) 495-3224 (telephone), (780) 495-3214 (fax).

Interventions must be filed with the Secretary General, Canadian Radio-television and Telecommunications Commission, Ottawa, Ontario K1A 0N2, together with proof that a true copy of the intervention has been served upon the applicant, on or before the deadline given in the notice.

Secretary General

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

DECISIONS

The complete texts of the decisions summarized below are available from the offices of the CRTC.

2005-537 October 31, 2005

Corus Premium Television Ltd.
Hamilton, Ontario

Approved — Authority to use a subsidiary communications multiplex operations channel for the purpose of broadcasting a predominantly Tamil-language radio service.

2005-538 October 31, 2005

Prescott Sandhu, on behalf of a not-for-profit corporation to be incorporated
Vanderhoof, British Columbia

Denied — Broadcasting licence to operate an English-language religious Type B community FM radio programming undertaking in Vanderhoof.

[46-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

PUBLIC NOTICE 2005-100

The Commission has received the following application. The deadline for submission of interventions and/or comments is December 6, 2005.

1. Jim Pattison Broadcast Group Ltd. (the general partner) and Jim Pattison Industries Ltd. (the limited partner), carrying on business as Jim Pattison Broadcast Group Limited
Partnership (JPBG)

Kamloops, Chase, Clinton, Merritt, 100 Mile House, Nicola, Pritchard and Quesnel, British Columbia

To amend the licence of the television programming undertaking CFJC-TV Kamloops.

November 1, 2005

[46-1-o]

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Haz-ardous Materials Information Review Commission hereby gives notice of the decisions of the Screening Officer respecting each claim for exemption and the relevant Material Safety Data Sheet (MSDS) and the label (where applicable), listed below.

Claimant	Product Identifier (As shown on the MSDS)	Registry Number	MSDS Preparation Date (As shown on the MSDS)	Date of Decision
Rohm and Haas Canada Inc., West Hill, Ontario	MONOMER QM-516, EXPERIMENTAL	4994	03/15/01	August 31, 2005 le 31 août 2005
Lord Corporation, Erie, Pennsylvania	CHEMLOK 7701	5205	9/29/2003	September 19, 2005 le 19 septembre 2005
Lord Corporation, Erie, Pennsylvania	CHEMLOK 7707	5206	9/29/2003	September 16, 2005 le 16 septembre 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 335 Performance Additive	5321	15 June 2004	September 16, 2005 le 16 septembre 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 350 Performance Additive	5322	9 June 2004	September 16, 2005 le 16 septembre 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 385 Performance Additive	5323	7 June 2004	September 16, 2005 le 16 septembre 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 8700 UTTO	5326	6/15/2004	July 20, 2005 le 20 juillet 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 509 Performance Additive	5359	9 June, 2004	August 23, 2005 le 23 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 596 Performance Additive	5365	1/21/2004	July 7, 2005 le 7 juillet 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 5739 Performance Additive	5368	21 January, 2004	August 25, 2005 le 25 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 2545 Performance Additive	5369	1/28/2004	July 12, 2005 le 12 juillet 2005
Kop-Coat, Pittsburgh, Pennsylvania	Beta 900	5372	10/15/2004	July 21, 2005 le 21 juillet 2005
Cognis Canada Corporation, Mississauga, Ontario	STANTEX 3124	5409	04/19/2002	July 7, 2005 le 7 juillet 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 8701 UTTO Performance Additive	5415	6/15/2004	July 20, 2005 le 20 juillet 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 543 Performance Additive	5436	23 January, 2004	August 23, 2005 le 23 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 1229 Performance Additive	5447	February 24 2004 (English/ anglaise) 24 Février 2004 (French/ française)	August 30, 2005 le 30 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 8129 Performance Additive	5448	February 23 2004 (English/ anglaise) 23 Février 2004 (French/ française)	August 30, 2005 le 30 août 2005
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL® 560H	5454	10 September 2004	August 30, 2005 le 30 août 2005
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL® 9108E	5455	29 March 2004	September 26, 2005 le 26 septembre 2005
3M Canada Company, London, Ontario	3M SDS-2 DUST SUPPRESSANT	5459	13/04/2004	July 5, 2005 le 5 juillet 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 521G Performance Additive formerly/ antérieurement HiTEC 521G	5465	February 24 2004 (English/ anglaise) 24 Février 2004 (French/ française)	August 31, 2005 le 31 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 521 Performance Additive	5480	February 24 2004 (English/ anglaise) 24 Février 2004 (French/ française)	August 31, 2005 le 31 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 315 Performance Additive	5481	24 February 2004	September 1, 2005 le 1^er septembre 2005
Air Products and Chemicals Inc., formerly/ antérieurement Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania	AQUAMINE* 401 CURING AGENT	5491	October 2002	September 22, 2005 le 22 septembre 2005
Air Products and Chemicals Inc., formerly/ antérieurement Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania	ENVIROGEM* AD01 SURFACTANT	5512	September 2002	September 21, 2005 le 21 septembre 2005
Schlumberger Canada Limited, Calgary, Alberta	Methanol Surfactant Foamer F107	5528	05 August 2004	August 22, 2005 le 22 août 2005
Afton Chemical Corporation, formerly/ antérieurement Ethyl Corporation, Richmond, Virginia	HiTEC 6543 Fuel Additive	5559	2 June 2004	July 7, 2005 le 7 juillet 2005
Schlumberger Canada Limited, Calgary, Alberta	Corrosion Inhibitor A264	5566	10-March-2003	August 18, 2005 le 18 août 2005
Air Products and Chemicals Inc., formerly/ antérieurement Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania	SURFYNOL * DF-75 Defoamer formerly/antérieurement SURFYNOL® DF-75 Defoamer	5575	February 2003	September 26, 2005 le 26 septembre 2005
Enthone Inc., West Haven, Connecticut formerly/ antérieurement Enthone-OMI (Canada) Inc., Mississauga, Ontario	ENPLATE^TM PNI-1000 A-W/ ENPLATE^MC PNI-1000 A-W	5577	July 26, 2003 (English/ anglaise) 26 Juliet (sic) 2003 (French/ française)	September 16, 2005 le 16 septembre 2005
Enthone Inc., West Haven, Connecticut formerly/ antérieurement Enthone-OMI (Canada) Inc., Mississauga, Ontario	ENPLATE^TM USI-220Y/ ENPLATE^MC USI-220Y	5578	July 26, 2003 (English/ anglaise) 26 Juliet (sic) 2003 (French/ française)	September 21, 2005 le 21 septembre 2005
Dow Chemical Canada Inc., Varennes, Quebec	UCARSOL(TM) NH SOLVENT 602/ SOLVANT UCARSOL(MC) NH 602	5580	2003.04.07	August 8, 2005 le 8 août 2005
Baker Petrolite Corp., Sugar Land, Texas	CRONOX^® 277	5591	4/28/2003	August 25, 2005 le 25 août 2005
Hydro Technologies (Canada) Inc., Sainte-Foy, Quebec	HY BRITE® CB4	5595	April 1, 2003 (English/ anglaise) 1 avril 2003 (French/ française)	August 3, 2005 le 3 août 2005
Cognis Canada Corporation, Mississauga, Ontario	DEHYPOUND HSC 5515	5600	05/12/2003	July 7, 2005 le 7 juillet 2005
Baker Petrolite Corp., Sugar Land, Texas	TRICAN S-8	5605	5/28/2003	July 20, 2005 le 20 juillet 2005
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® E-5	5606	11/25/2003	August 22, 2005 le 22 août 2005
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® E-11	5607	11/25/2003	August 22, 2005 le 22 août 2005
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® E-64R	5608	11/25/2003	August 22, 2005 le 22 août 2005
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ACAR 03010	5609	June 2, 2003	August 22, 2005 le 22 août 2005
Rohm and Haas Canada Inc., West Hill, Ontario	UCD 5721V Trans Yellow Oxide	5618	06/11/03	August 30, 2005 le 30 août 2005
Rohm and Haas Canada Inc., West Hill, Ontario	UCD 8443V Quinacridone Violet	5619	06/11/03	August 30, 2005 le 30 août 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	FM ^® 73 M Adhesive Film	5635	02/26/2004	September 12, 2005 le 12 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM ^® AEL 200-1/1100 Structural Adhesive	5638	02/26/2004	September 12, 2005 le 12 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® 799 Structural Resin	5642	02/26/2004	August 15, 2005 le 15 août 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	FM® 300U ECS Adhesive Film	5645	02/26/2004	September 27, 2005 le 27 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® 8522 Structural Prepreg	5649	02/26/2004	September 19, 2005 le 19 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	METLBOND® 6726 Primer	5650	02/10/2004	August 16, 2005 le 16 août 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® 5216 Structural Prepreg - Solution Coat	5657	07/28/2003	September 19, 2005 le 19 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® 5216 Structural Prepreg - Hot Melt	5658	07/28/2003	September 19, 2005 le 19 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® 919LB Structural Prepreg	5660	07/28/2003	September 19, 2005 le 19 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® 919 Prepreg	5663	07/28/2003	September 19, 2005 le 19 septembre 2005
CYTEC INDUSTRIES INC., West Paterson, New Jersey	CYCOM® E-293FC/Aluminum Wire Mesh Prepreg	5667	07/28/2003	September 19, 2005 le 19 septembre 2005
Greensolv Inc., Baie-d'Urfé, Quebec	G-STRIP 130	5688	7/26/2003	August 5, 2005 le 5 août 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® SANSIN BLEND#1	5737	August 7, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® QUINACRIDONE RED	5739	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® QUINDO MAGENTA	5740	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® MONO AZO RED	5741	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® LEAD FREE ORANGE	5742	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® RED IRON OXIDE	5743	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® BURNT SIENNA	5744	August 18, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® BURNT UMBER	5745	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® YELLOW IRON OXIDE	5746	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® RAW UMBER	5747	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® LEAD FREE MEDIUM YELLOW	5748	August 6, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® ORGANIC YELLOW GS	5749	July 24, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® PHTHALO GREEN BS	5750	August 6, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® QUINACRIDONE VIOLET	5751	August 6, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® PHTHALO BLUE IS	5752	August 6, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® LAMP BLACK	5753	August 6, 2003	September 22, 2005 le 22 septembre 2005
Degussa Canada Inc., Brampton, Ontario	AQUA-CHEM® JET BLACK	5754	July 24, 2003	September 22, 2005 le 22 septembre 2005
Schlumberger Canada Limited, Calgary, Alberta	Surfactant D191	5757	15 May 2005	September 28, 2005 le 28 septembre 2005
Schlumberger Canada Limited, Calgary, Alberta	Surfactant D607	5758	22 May 2005	September 28, 2005 le 28 septembre 2005
Schlumberger Canada Limited, Calgary, Alberta	VDA J557	5759	11 February 2005	September 28, 2005 le 28 septembre 2005
BASF Canada Inc., Toronto, Ontario	Lutensol® XL 80	5761	2004/11/16	August 10, 2005 le 10 août 2005
Baker Petrolite Corp., Sugar Land, Texas	BPR 34001	5762	8/16/2004	August 24, 2005 le 24 août 2005
Hercules Canada Inc., Mississauga, Ontario formerly/ antérieurement Hercules Canada (2002) Inc., Burlington, Ontario	HERCULES® PPD D-1094 SOFTENER	5763	23-Mar-2003	August 19, 2005 le 19 août 2005
Rohm and Haas Canada Inc., West Hill, Ontario	Thixon 405 Clear	5771	09/19/2003	September 26, 2005 le 26 septembre 2005
Air Products and Chemicals Inc., formerly/ antérieurement Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania	DABCO ® DC5702 SURFACTANT	5772	03/27/2005	September 16, 2005 le 16 septembre 2005
Rohm and Haas Canada Inc., West Hill, Ontario	QM-1326 AP	5773	09/25/2003	September 12, 2005 le 12 septembre 2005
Schlumberger Canada Limited, Calgary, Alberta	Dev Gelling Agent XE983	5778	11 February 2005	September 28, 2005 le 28 septembre 2005
Dow Corning Canada Inc., Mississauga, Ontario	SYL-OFF(R) SL 2 CROSSLINKER formerly/ antérieurement DOW CORNING^® 2-7221 INTERMEDIATE	5779	2005/01/12	July 29, 2005 le 29 juillet 2005
Schlumberger Canada Limited, Calgary, Alberta	EZEFLO* F100 Surfactant	5782	08 April 2005	September 28, 2005 le 28 septembre 2005
Schlumberger Canada Limited, Calgary, Alberta	Foaming Agent F104	5783	04 May 2005	September 28, 2005 le 28 septembre 2005
Baker Petrolite Corp., Sugar Land, Texas	WCW142	5790	10/20/2003	August 25, 2005 le 25 août 2005
Baker Petrolite Corp., Sugar Land, Texas	RBW 112 REVERSE BREAKER	5794	1/29/2004	August 9, 2005 le 9 août 2005
Baker Petrolite Corp., Sugar Land, Texas	TOLAD^® 9715 ADDITIVE	5796	8/26/2004	August 26, 2005 le 26 août 2005
GE Canada Inc., Mississauga, Ontario	Niax® A-400	5807	2005.04.18	August 29, 2005 le 29 août 2005
GE Canada Inc., Mississauga, Ontario	Niax® A-440	5808	2005.05.03	August 29, 2005 le 29 août 2005
Baker Petrolite Corp., Sugar Land, Texas	PAW3900 PARAFFIN INHIBITOR	5828	6/10/2004	September 16, 2005 le 16 septembre 2005
Baker Petrolite Corp., Sugar Land, Texas	RE5295RBW WATER CLARIFIER formerly/ antérieurement RE5295RBW	5836	6/18/2004	September 7, 2005 le 7 septembre 2005
Cognis Canada Corporation, Mississauga, Ontario	TRYLUBE 7640	5837	04/29/2005	August 9, 2005 le 9 août 2005
Baker Petrolite Corp., Sugar Land, Texas	CRO9136 CORROSION INHIBITOR	5838	9/16/2004	September 9, 2005 le 9 septembre 2005
Hercules Canada Inc., formerly/ antérieurement Hercules Canada (2002) Inc., Mississauga, Ontario	INFINITY® PS4004 BLACK LIQUOR MODIFIER	5935	04-May-2004	August 9, 2005 le 9 août 2005
ARC Resins Corp., Longueuil, Quebec	Promoter AC-525/ Promoteur AC-525	5937	May 26 2004 (English/ anglaise) mai 26 2004 (French/ française)	September 8, 2005 le 8 septembre 2005
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® 82S formerly/ antérieurement REDICOTE 82S-1	5961	October 28, 2004	September 13, 2005 le 13 septembre 2005

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5323 to be the chemical identity of seven ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of six ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5372 to be the chemical identity of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of six ingredients.

3. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5415 to be the chemical identity of seven ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of five ingredients.

4. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5436 to be the chemical identity of five ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of seven ingredients.

5. The Notice of Filing published in the Canada Gazette, Part I, on December 14, 2002, listed the subject of the claims bearing Registry Numbers 5447 and 5448 to be the chemical identity of four ingredients. The subjects of the claims on which the Screening Officer issued the decisions are the chemical identities of two and one ingredient, respectively.

6. The Notice of Filing published in the Canada Gazette, Part I, on December 14, 2002, listed the subjects of the claims bearing Registry Numbers 5465 and 5480 to be the chemical identities of three and four ingredients, respectively. The subjects of the claims on which the Screening Officer issued the decisions are the chemical identities of one and two ingredients, respectively.

7. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5559 to be the chemical identity of two ingredients and the name of a toxicological study that identifies an ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients and the name of a toxicological study that identifies an ingredient.

8. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5575 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of four ingredients.

9. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5591 to be the chemical identity of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of five ingredients.

10. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5600 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of three ingredients.

11. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subjects of the claims bearing Registry Numbers 5606, 5607 and 5608 to be the chemical identities of two, two and four ingredients, respectively. The subjects of the claims on which the Screening Officer issued the decisions are the chemical identities of one, one and three ingredients, respectively.

12. The Notice of Filing published in the Canada Gazette, Part I, on November 1, 2003, listed the subject of the claim bearing Registry Number 5688 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of seven ingredients.

13. The Notice of Filing published in the Canada Gazette, Part I, on November 1, 2003, listed the subject of the claim bearing Registry Number 5737 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of three ingredients.

14. The Notice of Filing published in the Canada Gazette, Part I, on November 1, 2003, listed the subject of the claims bearing Registry Numbers 5739 to 5744, inclusively, and 5746 to 5754, inclusively, to be the chemical identity and concentration of three ingredients. The subject of the claims on which the Screening Officer issued the decisions is the chemical identity and concentration of two ingredients.

15. The Notice of Filing published in the Canada Gazette, Part I, on November 1, 2003, described the claim bearing Registry Number 5773 as seeking exemption from the disclosure of supplier confidential business information in respect of a controlled product; such disclosure would otherwise be required under the provisions of the Hazardous Products Act.

It has since been established that the claim was seeking exemption from the disclosure of employer confidential information in respect of a controlled product which would otherwise be required to be disclosed by the provisions of the applicable provincial legislation relating to occupational health and safety. The Screening Officer issued the decision on that basis.

16. The Notice of Filing published in the Canada Gazette, Part I, on November 1, 2003, listed the subject of the claim bearing Registry Number 5782 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of one ingredient.

There were no submissions from affected parties to the Screening Officer with respect to any of the above claims for exemption and related MSDSs.

Each of the claims for exemption listed above was found to be valid with the exception of the claims bearing Registry Numbers 5205 and 5206 which were found to be invalid. The Screening Officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the claims bearing Registry Numbers 5763 and 5837 complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 5528, 5566, 5757, 5758, 5759, 5778, 5782 and 5783, being claims from an employer in the province of Alberta, the Screening Officer found that the MSDSs and, in the case of the claim bearing Registry Number 5528, the label relating to these claims did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code of the Province of Alberta.

In the case of the claims bearing Registry Numbers 4994 and 5773, being claims from an employer in the province of Ontario, the Screening Officer found that the MSDSs relating to these claims did not comply with the applicable disclosure requirements of the Occupational Health and Safety Act of the Province of Ontario.

Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the remaining claims did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Number 4994

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of certain ingredients in an acceptable manner;

2. Disclose that acute inhalation of an ingredient in the controlled product has been shown to cause adverse lung effects in laboratory animals;

3. In relation to the first aid information for skin and eye contact already disclosed on the MSDS, add a statement to the effect that medical attention be obtained immediately.

Registry Numbers 5205 and 5206

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the chemical identity and CAS Registry Number of the confidential hazardous ingredient identified with the GCI halo cyclic amide;

2. Disclose the percent concentration of each hazardous ingredient in an acceptable manner;

4. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. Disclose oxides of carbon and nitrogen as hazardous combustion products;

6. Disclose procedures to be used in dealing with a leak or a spill;

7. Disclose that grounded equipment be used when handling large quantities of the controlled product;

8. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes of laboratory animals;

9. Registry Number 5205:

(a)Disclose an LC₅₀ (4 hours, female rat) value of 40.7 mg/L for ethyl acetate;

(b)Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the testes and accessory reproductive organs as well as causing behavioural effects in laboratory animals;

(c)Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity;

(d)If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;

10. Registry Number 5206:

(a)In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

(b)Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects and developmental effects in laboratory animals.

Registry Numbers 5321 to 5323, inclusive

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Add eye contact as a route of entry;

4. Disclose an LC₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;

6. Registry Number 5321: Disclose a dermal LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

7. Registry Number 5322: Add skin contact as a route of entry;

8. Registry Number 5323:

(a)Disclose the generic chemical identity of three additional confidential hazardous ingredients in the controlled product, disclose their concentrations in an acceptable manner and disclose that the real chemical identities are included in the claim for exemption;

(b)Disclose LD₅₀ values for one of the confidential hazardous ingredients;

(c)Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

9. Registry Numbers 5321 and 5322:

(a)Disclose the generic chemical identity of an additional confidential hazardous ingredient in the controlled product, disclose its concentration in an acceptable manner and disclose that the real chemical identity is included in the claim for exemption;

(b)Disclose that acute exposure to an ingredient in the controlled product has been shown to cause central nervous system depression in laboratory animals;

10. Registry Numbers 5322 and 5323:

(a)Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

(b)Disclose an oral LD₅₀ value for another of the confidential hazardous ingredients in an acceptable manner.

Registry Number 5326

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of calcium long-chain alkaryl sulfonate in an acceptable manner;

2. Change the statement "WHMIS Regulated?: No" shown in conjunction with the ingredient disclosed as calcium alkyl phenate sulfide phosphorous sulfide polyolefin to "WHMIS Regulated?: Yes";

3. Add oxides of sulfur to the list of hazardous thermal decomposition products;

4. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

5. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

6. Remove the statement that the controlled product is not irritating to the skin and disclose instead that an ingredient in the controlled product has been shown to cause skin irritation in laboratory animals.

Registry Number 5359

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Remove any indication that long-chain alkenyl amine is not a hazardous ingredient of the controlled product;

2. Disclose the generic chemical identity of two additional confidential hazardous ingredient in the controlled product, disclose their concentrations in an acceptable manner and disclose that the real chemical identities are included in the claim for exemption;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;

4. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with water for at least 30 minutes;

5. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals;

6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

Registry Number 5365

The claimant has been ordered to amend certain aspects of the wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

2. Add skin contact as a route of entry;

3. Clarify the damage potential of the controlled product as regards eye contact.

Registry Number 5368

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 5369

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add eye contact as a route of entry;

2. Disclose that ingredients in the controlled product have shown positive results in screening tests for mutagenicity;

3. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner.

Registry Number 5372

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;

2. Disclose a lower LD₅₀ value for one of the confidential hazardous ingredients;

3. Disclose the Exposure Limit Values ACGIH TLV–TWA = 2 mg/m and ACGIH TLV–STEL = 6 mg/m for one of the confidential hazardous ingredients;

4. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause neurological effects, cardiopulmonary effects and kidney damage;

5. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause testicular effects in laboratory animals;

6. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the bone marrow and liver as well as sperm effects in laboratory animals;

7. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to have adverse effects on the male reproductive system;

8. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals in the absence of maternal toxic effects.

Registry Number 5409

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose LD₅₀ values for one of the confidential hazardous ingredients.

Registry Number 5415

The claimant has been ordered to amend certain aspects of the wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of calcium long-chain alkaryl sulfonate in an acceptable manner;

2. Change the statement "WHMIS Regulated?: No" shown in conjunction with the ingredient disclosed as calcium alkyl phenate sulfide phosphorous sulfide polyolefin to "WHMIS Regulated?: Yes";

3. Add oxides of sulfur to the list of hazardous thermal decomposition products;

4. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

5. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

6. Remove the inference that the ingredient known as a methacrylate copolymer was a part of the claim for exemption.

Registry Number 5436

The claimant has been ordered to amend certain aspects of the wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the generic chemical identity of three additional confidential hazardous ingredients in the controlled product, disclose their concentrations in an acceptable manner and disclose that the real chemical identities are included in the claim for exemption;

2. Remove the concentration range shown for the confidential hazardous ingredient long chain alkenyl amide and disclose its actual concentration or an acceptable range value;

3. Add eye contact as a route of entry;

4. Disclose that an ingredient in the controlled product has shown positive results in an in vitro screening test for mutagenicity;

5. Disclose oral LD₅₀ values for three of the confidential hazardous ingredients in an acceptable manner.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Numbers 5447 and 5448

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of sulphur to the list of hazardous combustion products;

2. Registry Number 5448: Remove the statement that the controlled product is not irritating to the eyes and disclose that an ingredient in the controlled product has been shown to cause eye irritation in laboratory animals.

Registry Number 5454

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that ethylbenzene, n-nonane and 1,2,4-trimethylbenzene are regulated components of the controlled product;

2. In relation to the period of time shown on the MSDS for flushing the eyes with water should skin contact occur, delete the current reference to "fifteen minutes" and replace it with a time of at least "twenty minutes";

3. Disclose that hexane synergistically enhances the hearing loss caused by inhalation exposure to xylene in laboratory animals.

Registry Number 5455

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of sulphur to the list of hazardous combustion products.

Registry Number 5459

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

3. Disclose LD₅₀ values for two of the confidential hazardous ingredients in an acceptable manner;

4. Disclose that ingredients in the controlled product have been shown to cause severe skin irritation in laboratory animals;

5. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the spleen and the blood of laboratory animals.

Registry Number 5465

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen and sulphur to the list of hazardous combustion products.

Registry Number 5480

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 5481

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. Remove the concentration range shown for the confidential hazardous ingredient alkyl phosphate and disclose its actual concentration or an acceptable range value;

3. Remove the concentration range shown for the confidential hazardous ingredient long chain alkenyl amide and disclose its actual concentration or an acceptable range value.

Registry Number 5491

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of poly[oxy (methyl-1,2-ethanediyl)], alpha-(2-aminomethylethyl) -omega (2-aminomethylethoxy) and tetraethylenepentamine in an acceptable manner;

2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 5512

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of carbon to the list of hazardous combustion products.

Registry Number 5528

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;

In the opinion of the Screening Officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose the HMIRC Registry Number;

2. Disclose that the product may cause birth defects;

3. Disclose a statement similar to "ground and bond containers to prevent static discharge";

4. Disclose a statement similar to "no smoking permitted while working with this product";

5. Disclose detailed information regarding the personal protective equipment to be worn when handling the controlled product;

6. Disclose a statement similar to "do not breathe vapour, wear approved respirator";

7. Disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 5559

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to dilute with plenty of fluids and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

3. Add oxides of nitrogen to the list of hazardous decomposition products;

4. Add eye contact as a route of entry;

5. Disclose that inhalation of an ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals at maternally toxic dose levels;

6. Disclose an LD₅₀ (oral, rat) value of 8 400 mg/kg for naphtha (petroleum), light aromatic;

7. Disclose an LD₅₀ (oral, rat) value of 2 049 mg/kg and an LC₅₀ (rat, 6 hours) value of >227 ppm for 2-ethylhexanol.

Registry Number 5566

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of three additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Disclose that grounded equipment be used when handling the controlled product;

4. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum powder and magnesium metal, aluminum and zinc salts, boron trichloride, and cyanuric chloride;

5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;

6. Disclose that both acute ingestion of and acute dermal exposure to an ingredient in the controlled product have caused adverse vision effects as well as necrosis and haemorrhaging in the brain;

7. Disclose that chronic inhalation of an ingredient in the controlled product has caused diminished vision;

8. Disclose that an ingredient in the controlled product has shown positive results in in vivo screening tests for mutagenicity;

9. Disclose that the fatty acid has been shown to cause dermal sensitization in laboratory animals;

10. Disclose a lower LC₅₀ (4 hours, female rat) value of 520 ppm for prop-2-yn-1-ol;

11. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

12. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 5575

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of three additional confidential hazardous ingredients in the controlled product, together with their percent concentrations.

Registry Number 5577

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of acrylic polymer in an acceptable manner;

2. Disclose the presence of amorphous fumed silica in the controlled product, its CAS Registry Number 112945-52-5 and its percent concentration;

3. Disclose the presence of heavy aromatic naphtha (petroleum) in the controlled product, its CAS Registry Number 64742-94-5 and its percent concentration;

4. Disclose an LD₅₀ (oral, rat) value of 3 200 mg/kg for heavy aromatic solvent naphtha (petroleum);

5. Disclose the Exposure Limit Value ACGIH TLV-TWA = 20 ppm for 2-butoxyethanol acetate;

6. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes.

Registry Number 5578

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and D2B;

2. Disclose the percent concentration of polyfunctional acrylic polymer in an acceptable manner;

3. Disclose the presence of amorphous fumed silica in the controlled product, its CAS Registry Number 112945-52-5 and its percent concentration;

4. Disclose the presence of talc in the controlled product, its CAS Registry Number 14807-96-6 and its percent concentration;

5. Add oxides of nitrogen to the list of hazardous combustion products;

6. Disclose the Exposure Limit Value AIHA WEEL-TWA = 1 mg/m³ (skin) for polyfunctional acrylic polymer;

7. Disclose the Exposure Limit Values ACGIH TLV-TWA = 2 mg/m³ and OSHA PEL = 20 mppcf for talc. Specify that the values are applicable only if no asbestiform fibres are present and the material contains less than 1 percent crystalline silica;

8. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes of laboratory animals;

9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the lungs of laboratory animals;

10. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the lungs as well as tumours in laboratory animals;

11. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian and bacterial cells, in vitro;

12. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

13. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;

14. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to "fifteen minutes" and replace it with a time of "at least thirty minutes";

15. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "give large amounts of water."

Registry Number 5580

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20–30 minutes;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water at once";

3. Disclose LD₅₀ values for two of the confidential hazardous ingredients.

Registry Number 5591

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B;

2. Correct the impression that naphthalene, xylene and trimethylbenzenes are regulated components of the controlled product;

3. Disclose that ingestion of an ingredient in the controlled product can cause adverse central nervous system (CNS) effects in humans;

4. In relation to the first aid information shown on the MSDS for eye contact, disclose that immediate medical attention should be sought and that flushing should continue for at least 30 minutes;

5. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 30 minutes;

6. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

7. Disclose that kerosene has been classified as a confirmed animal carcinogen with unknown relevance to humans (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH);

8. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity;

9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause hardening of the arteries in laboratory animals;

10. Disclose that ingestion of an ingredient in the controlled product can cause adverse central nervous system (CNS) effects and gastrointestinal disturbances in humans;

11. Disclose an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropanol;

12. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals;

13. Disclose that diethylamine is a skin sensitizer;

14. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity in laboratory animals;

15. Disclose that exposure to vapours of an ingredient in the controlled product has caused temporary visual disturbances;

16. Disclose a lower LD₅₀ (oral, guinea pig) value of 16 300 mg/kg for kerosene;

17. Disclose an LD₅₀ range value for one of the confidential hazardous ingredients.

Registry Number 5595

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the statement and the hazard symbol indicating that the controlled product is classified in WHMIS class E. Also remove statements that the product is corrosive to the skin and that it is classified as corrosive for transport under the TDG regulations;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give several glasses of water or milk."

Registry Number 5600

The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.

Registry Number 5605

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that ethylbenzene and trimethylbenzenes are regulated components of the controlled product;

2. Disclose that acute ingestion of an ingredient in the controlled product has caused adverse gastrointestinal, CNS and vision effects as well as necrosis and haemorrhaging in the brain;

3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, boron trichloride and cyanuric chloride;

5. Disclose an LD₅₀ (oral, male rat) value of 3 523 mg/kg for xylene;

6. Disclose that hexane synergistically enhances the hearing loss caused by inhalation exposure to xylene in laboratory animals;

7. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause fetotoxicity in laboratory animals;

8. Disclose that xylene has been shown to cause skin sensitization in workers;

9. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo.

Registry Numbers 5606 to 5608, inclusive

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropanol;

3. Disclose that an ingredient in the controlled product is incompatible with 2-butanone, aluminum and potassium tert-butoxide and that an explosion may result if these ingredients are mixed with the controlled product;

4. Disclose an LC₅₀ (4 hours, rat) value of 17 000 ppm for isopropanol;

5. Disclose that acute inhalation of high doses of an ingredient in the controlled product has been shown to cause respiratory tract irritation and adverse lung effects;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;

7. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity in laboratory animals;

8. Disclose that ingestion of an ingredient in the controlled product can cause adverse central nervous system (CNS) effects and gastrointestinal disturbances in humans;

9. Remove the statement that the controlled product is practically non-toxic in contact with the skin;

10. Registry Number 5606: If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A;

11. Registry Number 5607:

(a)Disclose an LD₅₀ value for the confidential hazardous ingredient in an acceptable manner;

(b)If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1B, D2A and D2B;

12. Registry Number 5608: If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and D2B.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the Screening Officer.

Registry Number 5609

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the statement that the controlled product is practically non-toxic in contact with the skin.

Registry Numbers 5618 and 5619

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of solvent naphtha (petroleum), light aromatic and 2-methoxy-1-propanol acetate in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If swallowed, give two glasses of water to drink";

3. Registry Number 5618: Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects in laboratory animals;

4. Registry Number 5619: Disclose the percent concentration of solvent naphtha (petroleum), medium aliphatic in an acceptable manner.

Registry Numbers 5635 and 5638

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to describe the subheading Odour Threshold as "not applicable."

2. Registry Number 5635: Disclose correct information concerning the potential for polymerization of the controlled product;

3. Registry Number 5638: Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 5642

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose correct information concerning the odour threshold of the chemical.

Registry Number 5645

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose correct information concerning the odour threshold of the chemical;

2. Disclose that poly (aromatic glycidyl ether) has caused respiratory sensitization in one worker.

Registry Number 5649

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose correct information concerning the odour threshold of the chemical.

Registry Number 5650

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Value ACGIH TLV–TWA = 0.0005 ppm for strontium chromate;

2. In relation to the first aid information shown on the MSDS for inhalation, add that medical attention should be obtained immediately;

3. Disclose that grounded equipment be used when handling large quantities of the controlled product;

4. Disclose correct information concerning the odour threshold of the chemical.

Registry Numbers 5657 and 5658

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose correct information concerning the odour threshold of the chemical.

Registry Numbers 5660 and 5663

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS Registry Number and percent concentration;

2. Disclose correct information concerning the odour threshold of the chemical.

Registry Number 5667

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS Registry Number and percent concentration;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed. Contaminated clothing, including contaminated footwear and leather goods, should be removed under running water. Obtain medical advice immediately;

3. Disclose correct information concerning the odour threshold of the chemical.

Registry Number 5688

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of four additional confidential hazardous ingredients in the controlled product;

2. Disclose that the alcohol has been shown to cause dermal sensitization in laboratory animals;

3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the brain, thymus and skeletal muscles in laboratory animals;

4. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the kidneys in laboratory animals;

5. Disclose that dermal exposure to an ingredient in the controlled product has caused adverse CNS effects;

6. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

7. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in mammalian cells, in vitro;

8. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

9. Disclose an LD₅₀ (dermal, rabbit) value of >5 200 mg/kg and an LC₅₀ (4 hours, rat) value of 1 400 ppm for the alcohol;

10. Disclose an LC₅₀ (4 hours, male rat, aerosol) value of 3.6 mg/L for the organic acid;

11. Disclose an LD₅₀ (oral, rat) value of 14 500 mg/kg for one of the confidential hazardous ingredients.

Registry Number 5737

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause severe damage to the cornea of laboratory animals;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 30 minutes while holding eyelid(s) open and taking care not to rinse contaminated water into the unaffected eye or face;

3. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing.

Registry Numbers 5739 to 5744, inclusive

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause severe damage to the cornea of laboratory animals;

2. Disclose that acute inhalation exposure to an ingredient in the controlled product has caused CNS effects;

3. Disclose that ingestion of an ingredient in the controlled product has been shown to cause damage to the eyes of laboratory animals;

4. Disclose that a second ingredient in the controlled product has been shown to cause fetotoxic effects;

5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human, mammalian and bacterial cells, in vitro;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;

7. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 30 minutes while holding eyelid(s) open and taking care not to rinse contaminated water into the unaffected eye or face;

8. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing;

9. Registry Number 5744:

(a)Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the lymph nodes and kidneys and lung and auto-immune diseases;

(b)Disclose that ethylene oxide is incompatible with an ingredient in the controlled product and may cause an explosive reaction when mixed with the controlled product.

Registry Number 5745

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause severe damage to the cornea of laboratory animals;

3. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the lymph nodes and kidneys and lung and auto-immune diseases.

Registry Numbers 5746 to 5751, inclusive